Literature DB >> 12820404

Expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in astrocytic tumors.

Nam Keun Kim1, Jung Yong Ahn, Jihwan Song, Jin Kyeoung Kim, Jin Hee Han, Hee Jung An, Hyung Min Chung, Jin Yang Joo, Joong Uhn Choi, Kyu Sung Lee, Rabindra Roy, Doyeun Oh.   

Abstract

BACKGROUND: DNA is continuously damaged due to exposure to alkylating compounds or oxygen free radicals generated during normal cellular metabolism as well as to environmental mutagens. Several studies have shown that N-methylpurine-DNA-glycosylase (MPG) mRNA levels were lower in adult brain than in other tissues. Terminally differentiated and nonproliferating cells have a lower DNA repair capacity than proliferating cells from various organs, embryo, ovary and testis. If the DNA repair are not efficient, the damaged DNA may lead to tumorigenesis or cell death. This study was designed to investigate the association of tumorigenesis with MPG in astrocytic tumors.
MATERIALS AND METHODS: MPG mRNA expression and localization in astrocytic tumors and tumor-adjacent brain tissues was examined by reverse transcriptase-polymerase chain reaction (RT-PCR) and RNA in situ hybridization. The expression and intracellular localization of MPG protein was determined by immunohistochemistry.
RESULTS: MPG mRNA expression in RT-PCR was slightly higher in astrocytic tumor tissues than in brain tissues adjacent to tumor and in astrocytic tumor tissues, regardless of the tumor grades. MPG protein localization in immunohistochemical study was detected only in the nucleus of all tumor tissues. Interestingly, in brain tissues adjacent to tumor, immunohistochemical staining for MPG was not observed either in the nucleus or the cytoplasm. However, we could not detect MPG protein in the brain tissues adjacent to the tumor although MPG mRNA was detected in the tissues.
CONCLUSION: These results suggest an MPG's role in human astrocytic tumors and raise the possibility that the altered MPG expression and intracellular localization could be associated with astrocytic tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820404

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  XRCC1 and base excision repair balance in response to nitric oxide.

Authors:  James T Mutamba; David Svilar; Somsak Prasongtanakij; Xiao-Hong Wang; Ying-Chih Lin; Peter C Dedon; Robert W Sobol; Bevin P Engelward
Journal:  DNA Repair (Amst)       Date:  2011-10-29

Review 2.  The promotion of pediatric neurosurgery throughout the world.

Authors:  Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-09       Impact factor: 1.475

3.  N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.

Authors:  Jiang-bo Tang; David Svilar; Ram N Trivedi; Xiao-hong Wang; Eva M Goellner; Briana Moore; Ronald L Hamilton; Lauren A Banze; Ashley R Brown; Robert W Sobol
Journal:  Neuro Oncol       Date:  2011-03-03       Impact factor: 12.300

Review 4.  Balancing repair and tolerance of DNA damage caused by alkylating agents.

Authors:  Dragony Fu; Jennifer A Calvo; Leona D Samson
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

5.  Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.

Authors:  Ram N Trivedi; Xiao-hong Wang; Elena Jelezcova; Eva M Goellner; Jiang-bo Tang; Robert W Sobol
Journal:  Mol Pharmacol       Date:  2008-05-13       Impact factor: 4.436

6.  Repair of 3-methyladenine and abasic sites by base excision repair mediates glioblastoma resistance to temozolomide.

Authors:  Michael S Bobola; Douglas D Kolstoe; A Blank; Marc C Chamberlain; John R Silber
Journal:  Front Oncol       Date:  2012-11-30       Impact factor: 6.244

7.  Aberrant expression of N-methylpurine-DNA glycosylase influences patient survival in malignant gliomas.

Authors:  Ce Liu; Yanyang Tu; Jun Yuan; Xinggang Mao; Shiming He; Liang Wang; Guoqiang Fu; Jianhai Zong; Yongsheng Zhang
Journal:  J Biomed Biotechnol       Date:  2012-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.